Laurel Organics Ltd (530313) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Laurel Organics Ltd ₹56.52, price ₹31.00, upside +82.3%, quality 71 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Laurel Organics Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range ₹23.55 – ₹80.78 · fair‑value band ₹32.54 – ₹100.13 · the ₹31.00 price screens below the ₹56.52 fair value. Dashed = 300-day average. As of Oct 3, 2026.
Follow Laurel Organics in your weekly email
Every Wednesday you see whether Laurel Organics is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Laurel Organics Ltd manufactures and sells pharmaceutical-bulk drugs in India.
Show more
Laurel Organics Ltd manufactures and sells pharmaceutical-bulk drugs in India. The company offers Benfotiamine, Cilnidipine, Gliclazide, Levosulpride, Rosuvastatin Calcium, Tranexamic Acid, Benidipine, Teneligliptin Hydrate Hydrobromide, Acotiamide, Citicoline Sodium, Luliconazole, Deflazacort, Voglibose, Oxaceprol, Ursodeoxycholic Acid, Bacitracin Zinc, Isotretinoin, and Tretinoin, as well as vitamin B1, calcium channel blocker, central stimulant/nootropic agent, and choleretic agent. It also provides products for various therapeutic categories, which comprise antidiabetic, antipsychotic, antihyperlipidemic, hemostatic, antihypertensive, antidiabetic, antiemetic, anti-fungal, anti-inflammatory, and anti-acne. The company was incorporated in 1993 and is based in New Delhi, India. Laurel Organics Ltd is a subsidiary of Kimia Biosciences Ltd.
Stock analysis
Laurel Organics Ltd (530313) currently trades at ₹31.00, while our model-based Fair Value estimate is ₹56.52, implying the stock looks roughly 45.2% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹89.80 per share, and 21 of the 24 models we run sit above the ₹31.00 price.
Bear case: the Economic Profit group reads lowest at ₹14.90, and 3 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹32.54 (bear) to ₹100.13 (bull), the price of ₹31.00 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 71/100 (solid quality), in the Other sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Laurel Organics Ltd reported revenue of ₹1.2B in FY2025 versus ₹1.3B in FY2021, a compound −2.7%/yr. Reported net income was ₹96.1M in FY2025, compounding +17.1%/yr from FY2021.
Key figures
Market cap ₹1.5B (≈ $15.2M) · P/E ratio 55.9 · P/S ratio 4.52 · EPS (TTM) ₹0.5405 · Net margin 8.1% · Return on assets (EBIT) 1.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 22% below its 52-week high and 32% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Other peers we cover trades at −10% fair-value upside, at 82%, 530313 screens cheaper than that median.
Fair Value models
Bear ₹32.54Fair Value ₹56.52Bull ₹100.13
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then (₹0.5405 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.54/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+13.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.3%
Start year 2020 (pandemic). Over 10 years: +52.5% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.3%
’14
’15
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+13.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+13.5%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.3% → 14%
⚠ Revenue per share shrinking 11.5%/yr over ~6Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Other · 125 stocks
Beats the industry median on 7/9 measures
Overall it ranks above its industry peers.
Valuation
Quality Score71 · Top 25%
Fair Value upside+82.3% · Top 25%
Profitability
Return on assets0.0% · Above median
Net margin (TTM)8.1% · Above median
Operating margin (TTM)0.0% · Above median
Growth and dividend
Revenue growth0.0% · Top 25%
Balance sheet
Debt / equity1.53× · Highest 25%
Valuation Multiplesvs Other median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Laurel Organics Ltd (530313) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of ₹56.52 versus a price of ₹31.00, about +82% upside (undervalued).
What is the fair value of 530313?
Our model-based fair value for Laurel Organics Ltd is ₹56.52 (as of Oct 3, 2026), built from audited fundamentals. The current price: ₹31.00.
What is the quality score of 530313?
Laurel Organics Ltd has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Laurel Organics Ltd (530313)?
Our model-based price target is the fair value of ₹56.52 (as of Oct 3, 2026) from 24 valuation models. Cautious scenario ₹32.54, optimistic scenario ₹100.13. It is a calculation from audited fundamentals, not an analyst target.
What is the Laurel Organics Ltd stock forecast for 2026?
Our models put fair value at ₹56.52, about +82% upside versus a price of ₹31.00 (undervalued). Cautious scenario ₹32.54, optimistic scenario ₹100.13. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Laurel Organics Ltd (530313)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Laurel Organics Ltd it is ₹56.52 per share (as of Oct 3, 2026), against a price of ₹31.00. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Laurel Organics Ltd stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 530313 trades below its calculated fair value: price ₹31.00, fair value ₹56.52, a gap of about +82% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 530313?
No. The price is what the market pays today (₹31.00); the fair value is what the company's own numbers justify (₹56.52). For Laurel Organics Ltd the two are ₹25.52 per share apart. That gap is exactly why we show both numbers side by side.
How much is Laurel Organics Ltd worth?
The market values Laurel Organics Ltd at about ₹1.5B (market capitalisation, as of Oct 3, 2026). Per share that is ₹31.00; our models calculate a fair value of ₹56.52 per share.
What do the bullish and bearish scenarios say about 530313?
Our models span a range for Laurel Organics Ltd: cautious scenario ₹32.54, base ₹56.52, optimistic ₹100.13 per share (as of Oct 3, 2026, price ₹31.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 530313?
Laurel Organics Ltd trades at a price-to-earnings ratio of 55.9 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹56.52 is built from several models across several years. Other multiples: P/B 0.2.
How solid is the balance sheet of Laurel Organics Ltd (530313)?
Balance-sheet figures for Laurel Organics Ltd (as of Oct 3, 2026): debt of 1.53 per unit of equity. They feed the Quality Score of 71/100, which measures business quality independently of the share price.
How far is 530313 from its 52-week high?
Laurel Organics Ltd trades at ₹31.00, about 22% below its 52-week high of ₹39.95 and 32% above the low of ₹23.55 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹56.52 is for.
Which stocks are comparable to Laurel Organics Ltd?
From the same area (Other) we also value 542772, 590024, Indiabulls Real Estate Limited, 542851, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Laurel Organics Ltd stock attractive at the current price?
The data as of Oct 3, 2026: price ₹31.00, calculated fair value ₹56.52 (+82%), Quality Score 71/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 530313 calculated?
We run Laurel Organics Ltd through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹56.52, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Laurel Organics Ltd currently trades 45 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Laurel Organics Ltd (530313)?
The closing price on Oct 1, 2026 was ₹31.00. Our model-based fair value is ₹56.52, about +82% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Laurel Organics Ltd right now?
The rarer combination: high quality (71/100) AND below fair value. That earns a closer look rather than a quick verdict. The price is below even our cautious bear case (₹32.54). The market is more pessimistic than our downside scenario. The model range is unusually wide (₹32.54 to ₹100.13). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Laurel Organics Ltd
How large is the market capitalisation of Laurel Organics Ltd (530313)?
The market capitalisation of Laurel Organics Ltd is ₹1.5B (≈ $15.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Laurel Organics Ltd (530313)?
The price-to-sales ratio of Laurel Organics Ltd is 4.52 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Laurel Organics Ltd (530313)?
Earnings per share at Laurel Organics Ltd are ₹0.5405 (price ÷ EPS = P/E 55.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Laurel Organics Ltd (530313)?
The net margin of Laurel Organics Ltd is 8.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Laurel Organics Ltd (530313)?
On an EBIT basis the return on assets of Laurel Organics Ltd is 1.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
Free · no account needed
Watch Laurel Organics Ltd in the live analysis
One click puts Laurel Organics Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
